PAPPA and endothelial dysfunction: Previous reports demonstrated that miR-149-5p could alleviate endothelial injury caused by oxidized low-density lipoprotein (ox-LDL) through inhibiting PAPP-A [41] and reduce endothelial dysfunction induced by high glucose through decreasing TNF-α and ER stress marker expression [42].